Efficacy of postoperative adjuvant hepatic artery infusion chemotherapy for hepatocellular carcinoma in microvascular invasion: a propensity-matched score
PA-HAIC is beneficial for HCC patients with MVI after radical liver resection, and patients aged ≤55 years with MVI + tumor diameter ≥5 cm, MVI + multiple tumors or MVI + tumor diameter ≥5 cm + multiple tumors should receive at least two PA-HAIC treatments.
Authors
- Xinhua Wu (ORCID: https://orcid.org/0000-0003-4625-9635)
- Yupei Ao
- Kai Chen (ORCID: https://orcid.org/0000-0002-3930-8294)
- Feng Xu (ORCID: https://orcid.org/0000-0003-0902-2858)
- Zheng‐Rong Shi
- Yixuan Gong
Institutions
- Chongqing Maternal and Child Health Hospital (CN)
- Deyang Stomatological Hospital (CN)
- The Affiliated Yongchuan Hospital of Chongqing Medical University (CN)
- First People's Hospital of Chongqing (CN)
- Chongqing Medical University (CN)
Publication Details
- Journal
- Frontiers in Surgery
- Published
- 2025-10-03
- DOI
- https://doi.org/10.3389/fsurg.2025.1619772
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00